Journal article
Immunopeptidomic profiling of HLA-A2-positive triple negative breast cancer identifies potential immunotherapy target antigens
- Abstract:
-
The recent development in immune checkpoint inhibitors and chimeric antigen receptor (CAR) T-cells in the treatment of cancer has not only demonstrated the potency of utilising T-cell reactivity for cancer therapy, but has also highlighted the need for developing new approaches to discover targets suitable for such novel therapeutics. Here we analysed the immunopeptidomes of 6 HLA-A2-positive triple negative breast cancer (TNBC) samples by nano-ultra performance liquid chromatography tandem m...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Authors
Funding
+ Breast Cancer Now
More from this funder
Funding agency for:
Olde Nordkamp, M
Grant:
2012NovemberPR004
Bibliographic Details
- Publisher:
- Wiley Publisher's website
- Journal:
- Proteomics Journal website
- Volume:
- 18
- Issue:
- 12
- Article number:
- 1700465
- Publication date:
- 2018-05-22
- Acceptance date:
- 2018-05-11
- DOI:
- EISSN:
-
1615-9853
- ISSN:
-
1615-9861
- Pmid:
-
29786170
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:853719
- UUID:
-
uuid:7f986a73-f7c2-431d-a2a6-63084f58ce2c
- Local pid:
- pubs:853719
- Deposit date:
- 2018-05-30
Terms of use
- Copyright holder:
- © 2018 Ternette, et al Proteomics Published by WILEY‐VCH Verlag GmbH and Co KGaA, Weinheim
- Copyright date:
- 2018
- Notes:
- This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record